From: Delayed linkage to HIV care among asylum seekers in Quebec, Canada
Overall (n = 139) | First diagnosed in Canada (n = 60) | First diagnosed before arrival to Canada (n = 79) | |
---|---|---|---|
HIV Genotype available | 80 (58%) | 57 (95%) | 23 (29%) |
Baseline antiretroviral resistancea | |||
No | 60 (75%) | 45 (79%) | 15 (65%) |
Yes | 20 (25%) | 12 (21%) | 8 (35%) |
NRTI resistance | 6 (8%) | 2 (4%) | 4 (17%) |
NNRTI resistance | 17 (21%) | 12 (21%) | 5 (22%) |
PI resistance | 0 (0%) | 0 (0%) | 0 (0%) |
II resistance | 1 (1%) | 1 (2%) | 0 (0%) |
Multidrug resistance | 3 (4%) | 2 (4%) | 1 (4%) |
M184 V/I mutation | 3 (4%) | 2 (4%) | 1 (4%) |
K103 N/S mutation | 11 (14%) | 7 (12%) | 4 (17%) |
K65R mutation | 0 (0%) | 0 (0%) | 0 (0%) |
TAMs | 1 (1%) | 1 (2%) | 0 (0%) |